Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 22, 2022 at 04:06 am EDT
Share
Hubei Jumpcan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 2,173.66 million compared to CNY 1,916.28 million a year ago. Revenue was CNY 2,173.66 million compared to CNY 1,916.28 million a year ago. Net income was CNY 581.19 million compared to CNY 439.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.654 compared to CNY 0.494 a year ago. Diluted earnings per share from continuing operations was CNY 0.642 compared to CNY 0.489 a year ago.
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.